Tax News Update    Email this document    Print this document  

March 8, 2021
2021-0519

IRS's advance pricing and mutual agreement program director discusses taxpayers' treatment of COVID-related costs

The IRS's program to resolve transfer pricing disputes (Advance Pricing and Mutual Agreement Program (APMA)) is seeing "questionable treatment of COVID-related costs," according to an article in Tax Notes Today.1

APMA director John Hughes said March 5, 2021, at the Federal Bar Association conference, that the APMA is seeing the following COVID-related issues: (1) taxpayers are classifying costs as nonoperating items to improve the controlled party's operating profitability for purposes of a comparable profits method or transactional net margin method analysis, which may result in a compensating adjustment; and (2) taxpayers with an advance pricing agreement nearing the end of its term are raising COVID-related issues prematurely, which may complicate bilateral competent authority negotiations.

Zeb Kelley, senior counsel for branch 6 of the IRS's Office of Chief Counsel, added that he is seeing taxpayers invoking force majeure to terminate arrangements, according to the article. "If there is reason to believe that unrelated parties in the same circumstances would not invoke force majeure, it raises questions," Kelley said. The arm's-length standard may require one of the parties to compensate the other for terminating the arrangement, Kelley added.

Kelley also said that the IRS is "eager" to finalize some version of the expired 2015 aggregation regulation and update the IRC Section 482 regulations to reflect the Tax Cuts and Jobs Act, according to the article.

Implications

Taxpayers should be cautious when taking non-conventional transfer pricing positions as a result of COVID-19. Although many of these issues have not yet been challenged, the comments by APMA director John Hughes' make it clear that they are on the IRS's radar. Furthermore, taxpayers that already have advance pricing agreements should consider all complications that may arise before attempting to raise COVID-related issues prematurely or invoking force majeure to terminate the arrangement entirely.

———————————————

Contact Information
For additional information concerning this Alert, please contact:
 
ITTS – Transfer Pricing Controversy
   • Ryan J. Kelly (ryan.j.kelly@ey.com)
   • Tom Ralph (thomas.ralph@ey.com)
   • Heather Gorman (heather.gorman@ey.com)
   • Matt Johnson (matt.p.johnson@ey.com)

———————————————
ENDNOTE

1 Ryan Finley, APMA Wary of Creative COVID-Related Transfer Pricing Positions, Tax Notes Today (March 8, 2021).

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement